About
HISUN is one of the local leading pharmaceutical companies in China. It was founded in 1956; And this year would be their 60th anniversary. Over past 59 years, their company has always had positive revenue since it was established. HISUN was publicly shared in 2000 in Shanghai Stock Exchange. They are the largest antibiotics, anticancer drugs production supplier. They provide diverse products and services. Their research channels cover many indications extensively: like anticancer, cardiovascular, anti-infective, anti-parasitics, immunosuppressant, etc. With the respect to annual revenue, R&D expenditure as well as its Social Record, HISUN is definitely top 10 among the 7000 local Chinese Pharma. They believe innovation launches the best treatment for healthcare.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 7 investors are based in Taizhou, Jiangsu, China.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Sectors
- healthtech biotech
- Location
- Taizhou, China
Contact Information
Find more investors like Zhejiang
Search Investors